Home › Leiomyosarcoma › Tennessee
Leiomyosarcoma clinical trials in Tennessee
4 studies for Leiomyosarcoma are looking for participants at sites in Tennessee.
Cities in Tennessee
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- University of Tennessee - Knoxville, Knoxville
- Vanderbilt University/Ingram Cancer Center, Nashville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT04031677NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Localized Leiomyosarcoma Biomarker Protocol
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jul 2, 2026 · NCT04925089Metastatic Leiomyosarcoma Biomarker Protocol
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2026 · NCT05653388From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.